ArticleBMC infectious diseases2025
Status of the scabies outbreak before, during and after the Covid- 19 pandemic: a single-center hospital-based retrospective evaluation.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Impact of Disease-Related Fear and Internalized Stigma on Quality of Life in Patients with Scabies: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Clinical presentation of scabies from 1996 to 2022: a retrospective cohort study from Finland.Scandinavian journal of primary health care · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScabies is an infestation that can be seen in all age groups, ethnicities, genders, socio-economic groups and in all societies. It is estimated that there are at least 200 million cases worldwide yearly. In this study, we aimed to evaluate the situation before, during and after Covid- 19.
methodsAll patients admitted to our outpatient clinic between January 1, 2017 and April 30, 2024 and patients diagnosed with scabies were included in our study and examined retrospectively. The age and gender of the patients, the number of patients admitted monthly and the number of patients diagnosed with scabies among them were evaluated monthly.
resultsBetween January 1, 2017 and April 30, 2024, 257,536 patients applied to our outpatient clinic. Of these patients, 9407 were diagnosed with scabies. When the percentage of cases was evaluated by years, it was observed that it started to increase in 2019, reached high levels and remained stable in 2020-2022, and then continued to rise in the first 4 months of 2023 and 2024.
conclusionAs a result, we found an increase in the number of scabies cases during the pandemic period. Although the rate of scabies cases is stable between 2020 and 2022, it is seen that the increase continues and will continue in 2023 and the following years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.